PRF Technologies (PRFX) Free Cash Flow (2020 - 2024)
PRF Technologies' (PRFX) quarterly Free Cash Flow came in at $3.5 million in Q2 2024, up 276.49% YoY from $938947.8 in Q3 2023, and up 195.85% on a QoQ basis from -$3.7 million in Q1 2024.
PRF Technologies (PRFX) Free Cash Flow (2020 - 2024) Analysis & Trends
PRF Technologies (PRFX) has 5 years of Free Cash Flow data on file, last reported at $3.5 million in Q2 2024.
- Quarterly Free Cash Flow rose 276.49% year-over-year to $3.5 million in Q2 2024, while the trailing twelve-month figure through Dec 2025 was $3.5 million (up 305.28% YoY) and the FY2025 annual result came in at -$4.0 million, up 68.68% from the prior year.
- Free Cash Flow advanced to $3.5 million in Q2 2024, from -$3.7 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $4.8 billion in Q3 2021 to a low of -$4.8 billion in Q4 2021.
- A 5-year average of -$1.2 million and a median of -$1.5 million in 2022 frame the typical range for Free Cash Flow.
- The widest YoY moves for Free Cash Flow: up 2185227.85% in 2021, down 236609.1% in 2021.
- Tracing PRFX's Free Cash Flow over 5 years: stood at -$2.0 million in 2020, then plunged by 236609.1% to -$4.8 billion in 2021, then surged by 99.94% to -$2.9 million in 2022, then surged by 45.29% to -$1.6 million in 2023, then jumped by 325.3% to $3.5 million in 2024.
- The last three Free Cash Flow figures came in at $3.5 million (Q2 2024), -$3.7 million (Q1 2024), and -$1.6 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | PRF Technologies | 647,973.00 | -3.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 3.54 Mn |
| Jun 30, 2024 | 3.54 Mn |
| Mar 31, 2024 | -3.69 Mn |
| Mar 31, 2024 | -3.69 Mn |
| Dec 31, 2023 | -1.57 Mn |
| Dec 31, 2023 | -1.57 Mn |
| Sep 30, 2023 | -1.16 Mn |
| Sep 30, 2023 | -1.16 Mn |
| Jun 30, 2023 | -2.00 Mn |
| Jun 30, 2023 | -2.00 Mn |
| Mar 31, 2023 | -1.95 Mn |
| Mar 31, 2023 | -1.95 Mn |
| Dec 31, 2022 | -2.87 Mn |
| Dec 31, 2022 | -2.87 Mn |
| Sep 30, 2022 | -892,000.00 |
| Sep 30, 2022 | -892,000.00 |
| Jun 30, 2022 | -1.35 Mn |
| Jun 30, 2022 | -1.35 Mn |
| Mar 31, 2022 | -1.35 Mn |
| Mar 31, 2022 | -1.35 Mn |